Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Conversion of 4,975,543 LTGO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Latigo Biotherapeutics, Inc. (LTGO) | Conversion | 4,975,543 | n/a |
| Aug 5, 2026 | Camp4 Therapeutics Corp (CAMP) | Purchase | 3,179,558 | $4.86M |
| Sep 16, 2025 | Camp4 Therapeutics Corp (CAMP) | Purchase | 2,941,176 | $4.50M |
| Oct 15, 2024 | Camp4 Therapeutics Corp (CAMP) | Conversion | 1,716,055 | n/a |
| Jul 24, 2024 | Artiva Biotherapeutics, Inc. (ARTV) | Conversion | 1,058,284 | n/a |
| Feb 16, 2024 | Enliven Therapeutics, Inc. (ELVN) | Sale | 688,358 | $10.26M |
| Feb 2, 2024 | Enliven Therapeutics, Inc. (ELVN) | Sale | 417,187 | $6.26M |
| Sep 28, 2023 | Enliven Therapeutics, Inc. (ELVN) | Sale | 164,789 | $2.47M |
| Aug 28, 2023 | Enliven Therapeutics, Inc. (ELVN) | Sale | 367,124 | $5.87M |
| Nov 19, 2021 | Vor Biopharma Inc. (VOR) | Sale | 238,870 | $3.65M |